U.S. markets open in 17 minutes

Applied DNA Sciences, Inc. (APDN)

NasdaqCM - NasdaqCM Precio retrasado. Divisa en USD.
Añadir a la lista de seguimiento
0.2900-0.0400 (-12.12%)
Al cierre: 04:00PM EDT
0.2600 -0.03 (-10.34%)
Antes de la apertura del mercado: 09:13AM EDT

Applied DNA Sciences, Inc.

50 Health Sciences Drive
Stony Brook, NY 11790
United States
631 240 8800
https://www.adnas.com

Sector(es)Healthcare
IndustriaDiagnostics & Research
Empleados a tiempo completo52

Ejecutivos clave

NombreTítuloPagarEjecutadoAño de nacimiento
Dr. James A. Hayward Ph.D., Sc.D.Chairman, President & CEO468kN/D1954
Ms. Beth M. Jantzen CPAChief Financial Officer300kN/D1976
Ms. Judith MurrahCOO, Chief Information Officer & Secretary325kN/D1958
Mr. Clay Shorrock Esq., J.D.Chief Legal Officer & Executive Director of Business Development300kN/D1985
Mr. Sanjay M. HurryExecutive Director of Investor Relations & Corporate CommunicationsN/DN/DN/D
Mr. Tony BensonManaging Director of EMEAN/DN/DN/D
Mr. Joseph L. MagnoSales ConsultantN/DN/DN/D
Mr. Warren PearlsonSales ConsultantN/DN/DN/D
Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Pago corresponde al salario, las bonificaciones, etc. Ejecutado corresponde al valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Applied DNA Sciences, Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment develops and commercializes the LinearDNA platform, which enables a cell-free manufacture of high-fidelity synthetic DNA sequences for use in nucleic acid-based therapeutics. The MDx Testing Services segment provides clinical molecular diagnostics (MDx) testing and clinical laboratory testing services; COVID-19 testing services, including test scheduling, sample collection, and automated results reporting for higher education institutions, private clients, and businesses under the safeCircle trademark; polymerase chain reaction (PCR) for production and detection of DNA and RNA; and MDx test kits and related supplies, as well as Isotopic analysis testing services. The DNA Tagging and Security Products and Services segment offers SigNature Molecular Tags, which provides a methodology to authenticate goods within large and complex supply chains for materials, such as cotton, nutraceuticals, and other products; SigNify portable DNA readers and SigNify consumable reagent test kits; and fiberTyping, which uses PCR-based DNA detection to detect a product's naturally occurring DNA sequences for the purposes of product provenance authentication and supply chain security. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.

Gestión corporativa

La calificación ISS Governance QuickScore de Applied DNA Sciences, Inc. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.

Las puntuaciones de la gestión corporativa son cortesía de Servicios de accionistas institucionales (ISS). Las puntuaciones indican una posición decil en relación con el índice o la región. Una puntuación decil 1 indica que el riesgo de gestión es menor, mientras que una puntuación decil 10 indica que el riesgo de gestión es mayor.